Elevance Health Inc. provided earnings guidance for the year 2022. The company now expects GAAP net income to be greater than $25.28 per share, including approximately $3.42 per share of net unfavorable items.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
534.3 USD | +0.83% | +1.09% | +13.32% |
02/05 | Factbox-Biggest cyber attacks in US healthcare sector | RE |
30/04 | Argus Raises Elevance Health's Price Target to $600 From $540 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.32% | 123B | |
-5.84% | 455B | |
+15.21% | 97.27B | |
+2.30% | 40.1B | |
-3.82% | 20.11B | |
-11.86% | 3.11B | |
-19.16% | 1.3B | |
-25.01% | 357M |
- Stock Market
- Equities
- ELV Stock
- News Elevance Health, Inc.
- Elevance Health Inc. Provides Earnings Guidance for the Year 2022